1365992-73-9

Basic information

• Product Name: 3-chloro-2-(4-chlorothiazolo[5,4-c]pyridin-2-yl)benzonitrile
• Synonyms: 3-chloro-2-(4-chlorothiazolo[5,4-c]pyridin-2-yl)benzonitrile
• CAS NO: 1365992-73-9
• Molecular Formula: C₁₃H₅Cl₂N₃S
• Molecular Weight: 306.17
• Mol File: 1365992-73-9.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-chloro-2-(4-chlorothiazolo[5,4-c]pyridin-2-yl)benzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 3-chloro-2-(4-chlorothiazolo[5,4-c]pyridin-2-yl)benzonitrile(1365992-73-9)
• EPA Substance Registry System: 3-chloro-2-(4-chlorothiazolo[5,4-c]pyridin-2-yl)benzonitrile(1365992-73-9)

Safety Data

• Hazardous Substances Data: 1365992-73-9(Hazardous Substances Data)

Upstream product

• 1365992-79-5 4-chloro-2-(2-chloro-6-nitrophenyl)thiazolo[5,4-c]pyridine 
• 1365992-78-4 2-chloro-N-(2-chloro-3-fluoropyridin-4-yl)-6-nitrobenzimidoyl chloride 
• 1365992-77-3 2-chloro-N-(2-chloro-3-fluoropyridin-4-yl)-6-nitrobenzamide 
• 1365992-71-7 2-bromo-6-chloro-N-(2-chloro-3-fluoropyridin-4-yl)-benzimidoyl chloride 
• 1365992-70-6 2-bromo-6-chloro-N-(2-chloro-3-fluoropyridin-4-yl)-benzamide 
• 148639-07-0 2-chloro-3-fluoro-4-iodopyridyne 
• 17282-04-1 2-chloro-3-fluoropyridine 
• 1365992-72-8 2-(2-bromo-6-chlorophenyl)-4-chlorothiazolo[5,4-c]pyridine 
• 1365992-80-8 3-chloro-2-(4-chlorothiazolo[5,4-c]pyridin-2-yl)-phenylamine 

Downstream Products

• 1365990-77-7 3-chloro-2-[4-(6-hydroxymethylpyrimidin-4-ylamino)thiazolo[5,4-c]pyridin-2-yl]-benzonitrile 
• 1365990-76-6 2-[4-(6-aminopyrimidin-4-ylamino)thiazolo[5,4-c]pyridin-2-yl]-3-chlorobenzonitrile 
• 1365992-74-0 2-(4-bromothiazolo[5,4-c]pyridin-2-yl)-3-chlorobenzonitrile 
• 1365992-76-2 C₂₇H₂₆ClN₇O₄S 
• 1365990-78-8 2-[4-(6-amino-2-methylpyrimidin-4-ylamino)-thiazolo[5,4-c]pyridin-2-yl]-3-chlorobenzonitrile hydrochloride salt 
• 1365992-82-0 C₂₈H₂₈ClN₇O₄S 

Relevant articles and documents

AZABENZOTHIAZOLE COMPOUNDS, COMPOSITIONS AND METHODS OF USE

Provided are compounds of Formula I, stereoisomers, tautomers, solvates, prodrugs and pharmaceutically acceptable salts thereof, wherein A, X, R1, R2, R4 and R5 are defined herein, a pharmaceutical composition that includes a compound of Formula I and a pharmaceutically acceptable carrier, adjuvant or vehicle, methods of using the compound or composition in therapy, and methods of 5 manufacturing a compound of Formula I